Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders
Open Access
- 18 December 2019
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (1) , 2
Abstract
Mesenchymal stromal cells (MSCs) are crucial elements in the bone marrow (BM) niche where they provide physical support and secrete soluble factors to control and maintain hematopoietic stem progenitor cells (HSPCs). Given their role in the BM niche and HSPC support, MSCs have been employed in the clinical setting to expand ex-vivo HSPCs, as well as to facilitate HSPC engraftment in vivo. Specific alterations in the mesenchymal compartment have been described in hematological malignancies, as well as in rare genetic disorders, diseases that are amenable to allogeneic hematopoietic stem cell transplantation (HSCT), and ex-vivo HSPC-gene therapy (HSC-GT). Dissecting the in vivo function of human MSCs and studying their biological and functional properties in these diseases is a critical requirement to optimize transplantation outcomes. In this review, the role of MSCs in the orchestration of the BM niche will be revised, and alterations in the mesenchymal compartment in specific disorders will be discussed, focusing on the need to correct and restore a proper microenvironment to ameliorate transplantation procedures, and more in general disease outcomes.Keywords
Funding Information
- Fondazione Telethon (SR-Tiget Core Grant)
This publication has 184 references indexed in Scilit:
- LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem CellsStem Cell Reports, 2013
- The potential use of mesenchymal stem cells in hematopoietic stem cell transplantationExperimental & Molecular Medicine, 2013
- The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move inJournal of Experimental Medicine, 2011
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHDBone Marrow Transplantation, 2010
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Senescent cells as a source of inflammatory factors for tumor progressionCancer and Metastasis Reviews, 2010
- Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineeringProceedings of the National Academy of Sciences, 2010
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow MicroenvironmentCell, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006